Company profile for Metsera

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Metsera is a clinical-stage biopharmaceutical company focused on spearheading the development of cutting-edge medicines and solutions for obesity and metabolic diseases. Founded in collaboration between Population Health Partners and ARCH Venture Partners, Metsera is fast-tracking the advancement of new medicines with potential best-in-class profiles. we are accelerating the discovery and development of innovative therapies ai...
Metsera is a clinical-stage biopharmaceutical company focused on spearheading the development of cutting-edge medicines and solutions for obesity and metabolic diseases. Founded in collaboration between Population Health Partners and ARCH Venture Partners, Metsera is fast-tracking the advancement of new medicines with potential best-in-class profiles. we are accelerating the discovery and development of innovative therapies aimed at addressing the significant unmet needs in the field of obesity and metabolic diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3 World Trade Ctr 175 Greenwich St New York, NY 10007 United States
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Pfizer Completes Acquisition Of Metsera
Pfizer Completes Acquisition Of Metsera

13 Nov 2025

// BUSINESSWIRE

https://www.businesswire.com/news/home/20251112938725/en/Pfizer-Completes-Acquisition-of-Metsera

BUSINESSWIRE
13 Nov 2025

https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-sweetens-offer-metsera-bidding-war-against-novo-bloomberg-news-reports-2025-11-08/

REUTERS
08 Nov 2025

https://www.globenewswire.com/news-release/2025/11/08/3184043/0/en/Novo-Nordisk-will-not-increase-its-proposal-to-acquire-Metsera-Inc.html

GLOBENEWSWIRE
08 Nov 2025

https://www.fiercepharma.com/www.fiercebiotech.com/biotech/ftc-tells-novo-its-metsera-offer-may-violate-us-merger-law-current-form

FIERCE PHARMA
05 Nov 2025

https://www.fiercebiotech.com/biotech/novo-nordisk-ceo-feels-danish-pharma-will-bag-metsera-end-pfizer-bidding-war

FIERCE BIOTECH
05 Nov 2025

https://www.fiercepharma.com//www.fiercebiotech.com/biotech/judge-knocks-down-pfizers-efforts-halt-novo-bid-metsera

FIERCE PHARMA
05 Nov 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty